Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2026-03-03 @ 12:38 AM
Study NCT ID:
NCT01773460
Status:
TERMINATED
Last Update Posted:
2016-02-10
First Post:
2013-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane
Sponsor:
GBG Forschungs GmbH
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GBG 76
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |